Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences is a blank-check company whose warrants trade under the ticker OACCW, sponsored by an affiliate of Oaktree Capital Management, the Los Angeles-based alternative investment firm known for its credit and distressed-debt strategies. The vehicle targets acquisition opportunities in the life sciences sector, encompassing biotechnology, pharmaceuticals, and healthcare services. The company completed its initial public offering in 2024 and filed a Form 10-Q with the SEC on August 12, 2025, indicating it remains in the search phase for a qualifying business combination. To access full filing history, sponsor analytics, and deal-stage tracking for this SPAC and hundreds of others, sign up for SpacDesk.